Conclusion
Overutilization of imaging is a remarkably pervasive and persistent phenomenon in localized prostate cancer—verified in this analysis in multiple large data sets and apparently worsening despite the downward risk migration of the disease. The upward trend is greatest for CT, with substantial resulting costs and risks. These findings highlight the need for a re-examination of the financial incentives and other factors that drive decision making regarding staging test utilization.